Adverum Biotechnologies Inc (NASDAQ:ADVM)

1.18
Delayed Data
As of Jul 01
 -0.025 / -2.08%
Today’s Change
0.80
Today|||52-Week Range
3.66
-33.24%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$106.7M

Company Description

Adverum Biotechnologies, Inc. is a clinical-stage gene therapy company that engages in the development of gene therapies for ocular and rare diseases. The company was founded by Mark S. Blumenkranz, Thomas W. Chalberg, Jr., Mitchell H. Finer, and Steven Daniel Schwartz on July 17, 2006 and is headquartered in Redwood City, CA.

Contact Information

Adverum Biotechnologies, Inc.
100 Cardinal Way
Redwood City California 94063
P:(650) 656-9323
Investor Relations:

Employees

Shareholders

Individual stakeholders4.47%
Other institutional35.21%
Mutual fund holders29.07%

Top Executives

Laurent FischerPresident, Chief Executive Officer & Director
Peter SoparkarChief Operating & Legal Officer
John W. RakowChief Financial Officer & Senior Vice President
Heikki JouttijärviSenior VP & Head-Technical Operations
Bill TanSVP & Head-Global Clinical Operations